StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker U.S. MedTech Industry Total by Quarter

U.S. MedTech Industry Total — FDA PMA Approvals (approvals)

QuarterlyAnnualMonthly

Stryker U.S. MedTech Industry Total: 565 in Q3 2026, down 3.4% from a year earlier.

Latest, Q3 2026
565
Period ended Sep 30, 2026
Change on a year earlier
-3.4%
585 in Q3 2025
History
51 quarters
Since Q1 2014
Sources
1
U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker

Where the Q3 2026 figure comes from

Source: U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. MedTech Industry Total — FDA PMA Approvals (approvals)Year on yearSource
Q3 2026Sep 30, 2026565-3.4%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2026Jun 30, 2026608+3.4%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2026Mar 31, 2026567+8.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2025Dec 31, 2025525-23.1%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q3 2025Sep 30, 2025585+8.7%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2025Jun 30, 2025588+6.9%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2025Mar 31, 2025524+14.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2024Dec 31, 2024683+4.1%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q3 2024Sep 30, 2024538-1.1%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2024Jun 30, 2024550-1.4%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2024Mar 31, 2024459+7.5%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2023Dec 31, 2023656+11.9%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q3 2023Sep 30, 2023544+11.2%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q2 2023Jun 30, 2023558+16.5%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q1 2023Mar 31, 2023427-20.6%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗
Q4 2022Dec 31, 2022586+2.6%U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗

Cite this data

StockData. (2026). Stryker U.S. MedTech Industry Total, quarterly Q1 2014–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/ext-fda-pma-ind

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.